[Use of adriablastin in the combination chemotherapy of disseminated breast cancer].
A course of combination chemotherapy using adriamycin was given to 68 patients suffering from disseminated breast tumor. Objective and symptomatic improvement was registered in 53 cases. Out of 45 patients with bone metastases, a distinct clinical effect was observed in 41 cases. Out of 10 bed-confined cases, seven became self-dependent. Mean remission in the cases of bone metastases was 6.4 months.
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage* / Q000009:adverse effects; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006321:Heart / Q000187:drug effects; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D013997:Time Factors
D004317:Doxorubicin
Primenenie adriablastina v kombinirovannoĭ khimioterapii disseminirovannogo raka molochnoĭ zhelezy.